Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Radosław Pracoń, John A. Spertus, Samuel Broderick et al. · Circulation Cardiovascular Interventions · 2024
BACKGROUND: ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) did not find an overall reduction in cardiovascular events with an initial invasive versus conservative management strategy in chronic coronary disease; however, there were conservative strategy participants who underwent invasive coronary angiography early postrandomization (within 6 months). Identifying factors associated with angiography in conservative strategy participants will inform clinical decision-making in patients with chronic coronary disease. METHODS: Factors independently associated with angiography performed within 6 months of randomization were identified using Fine and Gray proportional subdistribution hazard models, including demographics, region of randomization, medical history, risk factor control, symptoms, ischemia severity, coronary anatomy based on protocol-mandated coronary computed tomography angiography, and medication use. RESULTS: Among 2591 conservative strategy participants, angiography within 6 months of randomization occurred in 8.7% (4.7% for a suspected primary end point event, 1.6% for persistent symptoms, and 2.6% due to protocol nonadherence) and was associated with the following baseline characteristics: enrollment in Europe versus Asia (hazard ratio [HR], 1.81 [95% CI, 1.14-2.86]), daily and weekly versus no angina (HR, 5.97 [95% CI, 2.78-12.86] and 2.63 [95% CI, 1.51-4.58], respectively), poor to fair versus good to excellent health status (HR, 2.02 [95% CI, 1.23-3.32]) assessed with Seattle Angina Questionnaire, and new/more frequent angina prerandomization (HR, 1.80 [95% CI, 1.34-2.40]). Baseline low-density lipoprotein cholesterol <70 mg/dL was associated with a lower risk of angiography (HR, 0.65 [95% CI, 0.46-0.91) but not baseline ischemia severity nor the presence of multivessel or proximal left anterior descending artery stenosis >70% on coronary computed tomography angiography. CONCLUSIONS: Among ISCHEMIA participants randomized to the conservative strategy, angiography within 6 months of randomization was performed in <10% of patients. It was associated with frequent or increasing baseline angina and poor quality of life but not with objective markers of disease severity. Well-controlled baseline low-density lipoprotein cholesterol was associated with a reduced likelihood of angiography. These findings point to the importance of a comprehensive assessment of symptoms and a review of guideline-directed medical therapy goals when deciding the initial treatment strategy for chronic coronary disease. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01471522.
Cited by 2 works. doi:10.1161/circinterventions.123.013435 Open-access PDF
Authors
- Radosław Pracoń
- John A. Spertus
- Samuel Broderick
- Sripal Bangalore
- Frank W. Rockhold
- Witold Rużyłło
- Elena Alekseevna Demchenko
- Thuraia Nageh
- Gabriel Blacher Grossman
- Kreton Mavromatis
- Cholenahally Nanjappa Manjunath
- Paola Emanuela Poggio Smanio
- Gregg W. Stone
- G.B. John Mancini
- William E. Boden
- Jonathan D. Newman
- Harmony R. Reynolds
- Judith S. Hochman
- David Joel Maron
- John T. Doan
References
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- Initial Invasive or Conservative Strategy for Stable Coronary Disease
- Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease
- International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design
- Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals
- Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care
- Survival After Invasive or Conservative Management of Stable Coronary Disease
- Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial